Skip to main content
Top
Published in: BMC Gastroenterology 1/2016

Open Access 01-12-2016 | Research article

Useful condition of chromoendoscopy with indigo carmine and acetic acid for identifying a demarcation line prior to endoscopic submucosal dissection for early gastric cancer

Authors: Norifumi Numata, Shiro Oka, Shinji Tanaka, Yoshikazu Yoshifuku, Tomohiro Miwata, Yoji Sanomura, Koji Arihiro, Fumio Shimamoto, Kazuaki Chayama

Published in: BMC Gastroenterology | Issue 1/2016

Login to get access

Abstract

Background

Identifying a precise demarcation line (DL) is indispensable for pathological complete en bloc endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). We evaluated the useful condition of chromoendoscopy with indigo carmine and acetic acid for marking dots around lesions before ESD for EGC.

Methods

We examined 98 consecutive patients with 109 intramucosal EGCs (mean diameter, 17.8 ± 12.4 mm; main histologic type, 96 intestinal and 13 diffuse) resected by en bloc ESD after chromoendoscopy with indigo carmine and acetic acid between December 2012 and February 2014. The DL was identified by this technique just before ESD (mean chromoendoscopy observation time, 71.6 s); subsequently, marking dots were placed around the EGC. EGCs were classified into two groups: useful for identifying the DL or useless. Clinicopathological characteristics and clinical outcomes were evaluated in each group.

Results

Forty-two of the 109 cases (38.5 %) were determined useful for chromoendoscopy with indigo carmine and acetic acid. Multivariate analysis with logistic regression showed that macroscopic type (protruded or flat elevated-type) and atrophic border (the oral side of tumor) were independently associated with the usefulness of chromoendoscopy using indigo carmine and acetic acid for identifying the DL of EGCs (P < 0.05). The histologically positive horizontal margin after ESD was 0 % (0/42) in useful cases, and 7.5 % (5/67) in useless cases.

Conclusions

Before ESD, chromoendoscopy with indigo carmine and acetic acid can be used for creating precise markings in protruded or flat elevated-type EGC or at the atrophic border on the oral side of EGCs.
Literature
1.
go back to reference Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50:560–3.CrossRefPubMed Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50:560–3.CrossRefPubMed
2.
go back to reference Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.CrossRefPubMedPubMedCentral Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.CrossRefPubMedPubMedCentral
3.
go back to reference Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, et al. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54–8.CrossRef Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, et al. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54–8.CrossRef
4.
go back to reference Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63:243–9.CrossRefPubMed Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63:243–9.CrossRefPubMed
5.
go back to reference Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006;64:877–83.CrossRefPubMed Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006;64:877–83.CrossRefPubMed
6.
go back to reference Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kanao H, et al. Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection. Endoscopy. 2006;38:996–1000.CrossRefPubMed Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kanao H, et al. Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection. Endoscopy. 2006;38:996–1000.CrossRefPubMed
7.
go back to reference Imagawa A, Okada H, Kawahara Y, Takenaka R, Kato J, Kawamoto H, et al. Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy. 2006;38:987–90.CrossRefPubMed Imagawa A, Okada H, Kawahara Y, Takenaka R, Kato J, Kawamoto H, et al. Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy. 2006;38:987–90.CrossRefPubMed
8.
go back to reference Higashiyama M, Oka S, Tanaka S, Sanomura Y, Yoshida S, Hiyama T, et al. Outcome of endoscopic submucosal dissection for gastric epithelial neoplasm in relationship to endoscopic classifications of submucosal fibrosis. Gastric Cancer. 2013;16:404–10.CrossRef Higashiyama M, Oka S, Tanaka S, Sanomura Y, Yoshida S, Hiyama T, et al. Outcome of endoscopic submucosal dissection for gastric epithelial neoplasm in relationship to endoscopic classifications of submucosal fibrosis. Gastric Cancer. 2013;16:404–10.CrossRef
9.
go back to reference Higashiyama M, Oka S, Tanaka S, Numata N, Sanomura Y, Yoshida S, et al. Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection. Gastrointest Endosc. 2012;77:298–302.CrossRef Higashiyama M, Oka S, Tanaka S, Numata N, Sanomura Y, Yoshida S, et al. Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection. Gastrointest Endosc. 2012;77:298–302.CrossRef
10.
go back to reference Sanomura Y, Oka S, Tanaka S, Noda I, Higashiyama M, Imagawa H, et al. Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study. Gastric Cancer. 2012;15:97–105.CrossRefPubMed Sanomura Y, Oka S, Tanaka S, Noda I, Higashiyama M, Imagawa H, et al. Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study. Gastric Cancer. 2012;15:97–105.CrossRefPubMed
11.
go back to reference Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed
12.
go back to reference Numata N, Oka S, Tanaka S, Kagemoto K, Sanomura Y, Yoshida S, et al. Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection. Gastric Cancer. 2015;18:332–8.CrossRefPubMed Numata N, Oka S, Tanaka S, Kagemoto K, Sanomura Y, Yoshida S, et al. Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection. Gastric Cancer. 2015;18:332–8.CrossRefPubMed
13.
go back to reference Yao K, Yao T, Iwashita A. Determining the horizontal extent of early gastric carcinoma: two modern techniques based on differences in the mucosal microvascular architecture and density between carcinoma and non-carcinomatous mucosa. Dig Endosc. 2002;14:583–7.CrossRef Yao K, Yao T, Iwashita A. Determining the horizontal extent of early gastric carcinoma: two modern techniques based on differences in the mucosal microvascular architecture and density between carcinoma and non-carcinomatous mucosa. Dig Endosc. 2002;14:583–7.CrossRef
14.
go back to reference Kawahara Y, Takenaka R, Okada H, Kawano S, Inoue M, Tsuzuki T, et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig Endosc. 2009;21:14–9.CrossRefPubMed Kawahara Y, Takenaka R, Okada H, Kawano S, Inoue M, Tsuzuki T, et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig Endosc. 2009;21:14–9.CrossRefPubMed
15.
go back to reference Yamashita H, Kitayama J, Ishigami H, Yamada J, Miyato H, Kaisaki S, et al. Endoscopic instillation of indigo carmine dye with acetic acid enables the visualization of distinct margin of superficial gastric lesion; Usefulness in endoscopic treatment and diagnosis of gastric cancer. Dig Liver Dis. 2007;39:389–91.CrossRefPubMed Yamashita H, Kitayama J, Ishigami H, Yamada J, Miyato H, Kaisaki S, et al. Endoscopic instillation of indigo carmine dye with acetic acid enables the visualization of distinct margin of superficial gastric lesion; Usefulness in endoscopic treatment and diagnosis of gastric cancer. Dig Liver Dis. 2007;39:389–91.CrossRefPubMed
16.
go back to reference Iizuka T, Kikuchi D, Hoteya S, Yahagi N. The acetic acid + indigocarmine method in the delineation of gastric cancer. J Gastroenterol Hepatol. 2008;23:1358–61.CrossRefPubMed Iizuka T, Kikuchi D, Hoteya S, Yahagi N. The acetic acid + indigocarmine method in the delineation of gastric cancer. J Gastroenterol Hepatol. 2008;23:1358–61.CrossRefPubMed
17.
go back to reference Sakai Y, Eto R, Kasanuki J, Kondo F, Kato K, Arai M, et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest Endosc. 2008;68:635–41.CrossRefPubMed Sakai Y, Eto R, Kasanuki J, Kondo F, Kato K, Arai M, et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest Endosc. 2008;68:635–41.CrossRefPubMed
18.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
19.
go back to reference Higashiyama M, Oka S, Tanaka S, Sanomura Y, Imagawa H, Shishido T, et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc. 2011;23:290–5.CrossRefPubMed Higashiyama M, Oka S, Tanaka S, Sanomura Y, Imagawa H, Shishido T, et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc. 2011;23:290–5.CrossRefPubMed
20.
go back to reference Matsumoto A, Tanaka S, Oba S, Kanao H, Oka S, Yoshihara M, et al. Outcome of endoscopic submucosal dissection for colorectal tumors accompanied by fibrosis. Scand J Gastroenterol. 2010;45:1329–37.CrossRefPubMed Matsumoto A, Tanaka S, Oba S, Kanao H, Oka S, Yoshihara M, et al. Outcome of endoscopic submucosal dissection for colorectal tumors accompanied by fibrosis. Scand J Gastroenterol. 2010;45:1329–37.CrossRefPubMed
21.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
22.
go back to reference Sasaki A, Kitadai Y, Ito M, Tanaka S, Yoshihara M, Haruma K, Chayama K. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach. Oncology. 2004;66:379–87.CrossRefPubMed Sasaki A, Kitadai Y, Ito M, Tanaka S, Yoshihara M, Haruma K, Chayama K. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach. Oncology. 2004;66:379–87.CrossRefPubMed
23.
go back to reference Yao K, Iwashita A, Yao T. Early gastric cancer: proposal for a new diagnostic system based on microvascular architecture as visualized by magnified endoscopy. Dig Endosc. 2004;16:S110–7.CrossRef Yao K, Iwashita A, Yao T. Early gastric cancer: proposal for a new diagnostic system based on microvascular architecture as visualized by magnified endoscopy. Dig Endosc. 2004;16:S110–7.CrossRef
24.
go back to reference Otsuka Y, Niwa Y, Ohmiya N, Ando N, Ohashi A, Hirooka Y, et al. Usefulness of magnifying endoscopy in the diagnosis of early gastric cancer. Endoscopy. 2004;36:165–9.CrossRefPubMed Otsuka Y, Niwa Y, Ohmiya N, Ando N, Ohashi A, Hirooka Y, et al. Usefulness of magnifying endoscopy in the diagnosis of early gastric cancer. Endoscopy. 2004;36:165–9.CrossRefPubMed
25.
go back to reference Yao K, Oishi T, Matsui T, Yao T, Iwashita A. Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc. 2002;56:279–84.CrossRefPubMed Yao K, Oishi T, Matsui T, Yao T, Iwashita A. Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc. 2002;56:279–84.CrossRefPubMed
26.
go back to reference Yagi K, Aruga Y, Nakamura A, Sekine A, Umezu H. The study of dynamic chemical magnifying endoscopy in gastric neoplasia. Gastrointest Endosc. 2005;62:963–9.CrossRefPubMed Yagi K, Aruga Y, Nakamura A, Sekine A, Umezu H. The study of dynamic chemical magnifying endoscopy in gastric neoplasia. Gastrointest Endosc. 2005;62:963–9.CrossRefPubMed
27.
go back to reference Tanaka K, Toyoda H, Kadowaki S, Kosaka R, Shiraishi T, Imoto I, Shiku H, Adachi Y. Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy. J Gastroenterol. 2006;41:332–8.CrossRefPubMed Tanaka K, Toyoda H, Kadowaki S, Kosaka R, Shiraishi T, Imoto I, Shiku H, Adachi Y. Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy. J Gastroenterol. 2006;41:332–8.CrossRefPubMed
28.
go back to reference Tao G, Xing-Hua L, Ai-Ming Y, Wei-Xun Z, Fang Y, Xi W, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRefPubMed Tao G, Xing-Hua L, Ai-Ming Y, Wei-Xun Z, Fang Y, Xi W, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRefPubMed
29.
go back to reference Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology. 2000;37:513–22.CrossRefPubMed Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology. 2000;37:513–22.CrossRefPubMed
30.
go back to reference Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int. 2004;54:311–21.CrossRefPubMed Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int. 2004;54:311–21.CrossRefPubMed
31.
go back to reference Yoshino T, Shimoda T, Saitoh A, Nakanishi Y, Tazima Y, Shirasu T, et al. Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer (in Japanese with English abstract). Stomach Intestine. 1999;34:513–25. Yoshino T, Shimoda T, Saitoh A, Nakanishi Y, Tazima Y, Shirasu T, et al. Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer (in Japanese with English abstract). Stomach Intestine. 1999;34:513–25.
Metadata
Title
Useful condition of chromoendoscopy with indigo carmine and acetic acid for identifying a demarcation line prior to endoscopic submucosal dissection for early gastric cancer
Authors
Norifumi Numata
Shiro Oka
Shinji Tanaka
Yoshikazu Yoshifuku
Tomohiro Miwata
Yoji Sanomura
Koji Arihiro
Fumio Shimamoto
Kazuaki Chayama
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2016
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-016-0483-7

Other articles of this Issue 1/2016

BMC Gastroenterology 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.